NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors

NCT05881525 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: TC-N201 cells
DRUG: IL-2
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Nab-paclitaxel

Sponsor

TCRCure Biopharma Ltd.

Collaborators

[object Object]